Accordingly, Lee et al. 7 also identified that silencing FAM83A in breast cancer cells markedly resulted in decreased p-ERK and p-AKT expression while suppressing malignant phenotype both in vitro and in vivo. This evidence concerns the gene AKT1 and breast cancer.